PHASE III MEDICAL, INC. DEF14A

Company

LISATA THERAPEUTICS, INC.

Filed

February 10, 2006

Period of Report

March 17, 2006

Accession Number

0001157523-06-001418

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →